Emerging bone problems in patients infected with human immunodeficiency virus.

Area of Science:

• Bone Metabolism and Endocrinology
• Infectious Diseases
• Pharmacology

Background:

• A high incidence of osteopenia and osteoporosis is noted in individuals with human immunodeficiency virus (HIV).
• Bone complications, such as avascular necrosis and fractures, are reported in HIV-infected individuals.
• Alterations in bone metabolism are observed in people living with HIV, irrespective of antiretroviral therapy (ART).

Purpose of the Study:

• To summarize the current understanding of bone abnormalities in HIV-infected individuals.
• To highlight the association between HIV, antiretroviral therapy, and bone health.
• To provide guidance on managing bone loss in people living with HIV.

Main Methods:

• Review of existing literature on bone health in HIV-infected populations.
• Analysis of reported bone-related complications and metabolic changes.
• Examination of potential mechanisms linking HIV and ART to bone abnormalities.

Main Results:

• HIV infection is associated with increased rates of osteopenia and osteoporosis.
• Potent antiretroviral therapy may exacerbate bone density loss.
• Underlying mechanisms for bone abnormalities in HIV remain under investigation.

Conclusions:

• People living with HIV exhibit significant alterations in bone metabolism.
• Management of osteopenia and osteoporosis in HIV patients should align with general population guidelines.
• Nutritional supplements, exercise, and potentially hormone replacement or antiresorptive therapies are indicated for bone health in HIV-infected individuals.